Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection

Current HIV Research

Volumn 12, Issue 2, 2014, Pages 97-110

  Tavazzi, Eleonora ^b   Morrison, David ^a   Sullivan, Peter ^a   Morgello, Susan ^c   Fischer, Tracy ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CD16; CD163; HAND; HIV; Macrophage; Microglia; Neuroinflammation; Neuropathogenesis

Indexed keywords

CAPSID PROTEIN; CD16 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; VIMENTIN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; FC RECEPTOR; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; ASTROCYTE; AUTOPSY; BLOOD BRAIN BARRIER; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MICROGLIA; MIDDLE AGED; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PROTEIN EXPRESSION; SCORING SYSTEM; VIRUS ENCEPHALITIS; BRAIN; ENCEPHALITIS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; ENCEPHALITIS; HIV INFECTIONS; HUMANS; MACROPHAGES; MICROGLIA; RECEPTORS, CELL SURFACE; RECEPTORS, IGG;

EID: 84905673995     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X12666140526114956     Document Type: Article

References (23)

1. Simioni S, Cavassini M, Annoni JM, et al., Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010; 24(9): 1243-1250.
2. Borjabad A, Morgello S, Chao W, et al., Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog 2011; 7(9): e1002213.
3. Anthony IC, Ramage SN, Carnie FW, et al., Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005; 64(6): 529-36.
4. Fischer-Smith T and Rappaport J, Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 2005; 7(27): 1-26.
5. Ciardi A, Sinclair E, Scaravilli F, et al., The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study. Acta Neuropathol 1990; 81(1): 51-9.
6. Fischer-Smith T, Croul S, Sverstiuk AE, et al., CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001; 7(6): 528-41.
7. Fischer-Smith T, Croul S, Adeniyi A, et al., Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 2004; 164(6): 2089-99.
8. Fischer-Smith T, Bell C, Croul S, et al., Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol 2008; 14(4): 318-26.
9. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41(6): 778-85.
10. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 1996; 47(5): 1247-53.
11. Woods SP, Rippeth JD, Frol AB, et al., Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 2004; 26(6): 759-78.
12. Fabriek BO, Van Haastert ES, Galea I, et al., CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005.
13. Rezaie P and Male D, Microglia in Fetal and Adult Human Brain Can Be Distinguished from Other Mononuclear Phagocytes through Their Lack of CD163 Expression. Neuroembryology 2003; 2(3): 130-133.
14. Brahmachari S, Fung YK, and Pahan K, Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 2006; 26(18): 4930-9.
15. Sticozzi C, Belmonte G, Meini A, et al., IL-1beta induces GFAP expression in vitro and in vivo and protects neurons from traumatic injury-associated apoptosis in rat brain striatum via NFkappaB/Ca-calmodulin/ERK mitogen-activated protein kinase signaling pathway. Neuroscience 2013.
16. Zhang L, Zhao W, Li B, et al., TNF-alpha induced over-expression of GFAP is associated with MAPKs. Neuroreport 2000; 11(2): 409-412.
17. Wilhelmsson U, Li L, Pekna M, et al., Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 2004; 24(21): 5016-21.
18. Wallet MA, Rodriguez CA, Yin L, et al., Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 2010; 24(9): 1281-90.
19. Achim CL, Adame A, Dumaop W, et al., Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 2009; 4(2): 190-9.
20. Khanlou N, Moore DJ, Chana G, et al., Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol 2009; 15(2): 131-8.
21. Anthony IC, Ramage SN, Carnie FW, et al., Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 2006; 111(6): 529-538.
22. Cysique LA, Vaida F, Letendre S, et al., Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 2009; 73(5): 342-8.
23. Heaton RK, Franklin DR, Ellis RJ, et al., HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17(1): 3-16.